1. Home
  2. TECH vs PNW Comparison

TECH vs PNW Comparison

Compare TECH & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • PNW
  • Stock Information
  • Founded
  • TECH 1976
  • PNW 1985
  • Country
  • TECH United States
  • PNW United States
  • Employees
  • TECH N/A
  • PNW N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • PNW Electric Utilities: Central
  • Sector
  • TECH Health Care
  • PNW Utilities
  • Exchange
  • TECH Nasdaq
  • PNW Nasdaq
  • Market Cap
  • TECH 12.5B
  • PNW 10.2B
  • IPO Year
  • TECH 1989
  • PNW N/A
  • Fundamental
  • Price
  • TECH $74.78
  • PNW $87.96
  • Analyst Decision
  • TECH Buy
  • PNW Buy
  • Analyst Count
  • TECH 9
  • PNW 14
  • Target Price
  • TECH $80.67
  • PNW $80.12
  • AVG Volume (30 Days)
  • TECH 860.3K
  • PNW 1.2M
  • Earning Date
  • TECH 10-29-2024
  • PNW 11-06-2024
  • Dividend Yield
  • TECH 0.43%
  • PNW 4.00%
  • EPS Growth
  • TECH N/A
  • PNW 51.61
  • EPS
  • TECH 1.05
  • PNW 5.41
  • Revenue
  • TECH $1,159,060,000.00
  • PNW $4,890,039,000.00
  • Revenue This Year
  • TECH $6.90
  • PNW $4.07
  • Revenue Next Year
  • TECH $9.69
  • PNW $4.11
  • P/E Ratio
  • TECH $71.22
  • PNW $16.26
  • Revenue Growth
  • TECH 1.97
  • PNW 7.57
  • 52 Week Low
  • TECH $51.79
  • PNW $65.20
  • 52 Week High
  • TECH $85.57
  • PNW $91.57
  • Technical
  • Relative Strength Index (RSI)
  • TECH 47.19
  • PNW 46.15
  • Support Level
  • TECH $73.89
  • PNW $88.16
  • Resistance Level
  • TECH $80.12
  • PNW $90.91
  • Average True Range (ATR)
  • TECH 2.52
  • PNW 1.39
  • MACD
  • TECH -0.25
  • PNW -0.27
  • Stochastic Oscillator
  • TECH 12.61
  • PNW 16.72

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About PNW Pinnacle West Capital Corporation

Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in the largest nuclear plant in the US, Palo Verde. About half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.

Share on Social Networks: